News
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...
56m
AstraZeneca (LSE:AZN) TAGRISSO Shows Clinically Meaningful Survival Improvement In Lung Cancer Study
AstraZeneca (LSE:AZN) recently announced positive developments regarding TAGRISSO®'s survival benefits in treating non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback